Donate today and join the fight to achieve global malaria elimination targets.
Together we can make a significant contribution to achieving malaria elimination targets.
Improving the health of vulnerable communities and changing lives is at the heart of what we do and who we are.
Photo by Macau Photo Agency on Unsplash
A pneumonia of unknown cause detected in Wuhan, China was first reported to the World Health Organization (WHO) Country Office in China on 31 December 2019.
The outbreak was declared a Public Health Emergency of International Concern on 30 January 2020. On 11 February 2020, WHO announced a name for the new coronavirus disease: COVID-19
Symptoms range from a mild cough to pneumonia. Some people recover easily, others may get very sick very quickly.
The Victorian State Government has provided AUD$6 million to Peter Doherty Institute for Infection and Immunity (Doherty Institute) and Burnet Institute expedite development of new therapeutics, diagnostics, clinical research and the public health response to the novel coronavirus, known as COVID-19.
Watch the video below or view the news story for more information.
A point of care test for #COVID19 will be vital if the #virus gets beyond the containment phase to assist the proper allocation of resources. Burnet's Associate Professor David Anderson explains ... @TheDohertyInst @DanielAndrewsMP @JennyMikakos @unimelb @CrabbBrendan pic.twitter.com/AHa9oysZGP
— Burnet Institute (@BurnetInstitute) March 3, 2020
ACE2 inhibitors for treatment of COVID-19
Age-related immune dysfunction may underpin poor COVID-19 outcomes in the elderly
Antenatal and postnatal care remote contacts guidance
Anti-COVID-19 biological drugs for prevention and treatment
Coping with COVID-19: Young people’s health and wellbeing in Australia
COVASIM: Modelling COVID-19
COVID-19 antigens for PoC test development
COVID-19 Healthcare E-Learning Platform (CoHELP)
COVID-19 Journey Project
COVID-19 Vaccine Development
Experiences of receiving or providing maternity care during CoVID-19 pandemic: The CovMat Study
Feasibility study for a potential medically supervised injecting centre/drug consumption service for the ACT
Mapping of COVID-19-related pregnancy and perinatal research in Australia
National COVID-19 Clinical Evidence Taskforce
Neutralising antibody assays for COVID-19
Optimising Quarantine Study
Rapid review of maternal health recommendations related to the COVID-19 pandemic
SCOOP: Strengthening COVID-19 Communication in Pregnancy
STRIVE PNG: Stronger Surveillance and Systems Support for Rapid Identification and Containment of Resurgent or Resistant Vector-Borne Pathogens in Papua New Guinea
SuperMIX: The Melbourne Injecting Drug User Cohort Study
The Optimise Study: Optimising Isolation, Quarantine and Distancing for COVID-19
VOICE - Victorian Online Initiative for Community Engagement
To achieve better health for vulnerable communities in Australia and internationally by accelerating the translation of research, discovery and evidence into sustainable health solutions.
85 Commercial Road, Melbourne
VIC, 3004, Australia
Receive updates and IMPACT magazine.
Copyright © 2022 Burnet Institute. ABN: 49 007 349 984
This website was developed with the generous support of a donor.
Burnet Institute (Australia) is located on the traditional land of the Boon Wurrung people and we offer our respects to their Elders past and present.
We recognise and respect the continuation of cultural, spiritual and educational practices of Aboriginal and Torres Strait Islander peoples of this land.
